SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer

Yibo Xue(McGill University Health Centre), Sidong Huang(McGill University Health Centre)

Nature Communications

February 4, 2019

10.1038/s41467-019-08380-1

Cited by 189

Related Papers

Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss

|Nature Communications|2023|30

<scp>SMARCB1</scp> loss induces druggable cyclin <scp>D1</scp> deficiency via upregulation of <scp><i>MIR17HG</i></scp> in atypical teratoid rhabdoid tumors

|The Journal of Pathology|2020|19